Published in Dtsch Gesundheitsw on September 09, 1965
Inducibility of human beta-interferon gene in mouse L-cell clones. Nature (1982) 1.43
Human myoblasts as antigen-presenting cells. J Immunol (1992) 1.39
The structure of a thirty-six kilobase region of the human chromosome including the fibroblast interferon gene IFN-beta. Nucleic Acids Res (1981) 1.33
Differential expression of perforin in muscle-infiltrating T cells in polymyositis and dermatomyositis. J Clin Invest (1996) 1.24
Co-expression of ICAM-1, VCAM-1, ELAM-1 and Hsp60 in human arterial and venous endothelial cells in response to cytokines and oxidized low-density lipoproteins. Cell Stress Chaperones (1997) 1.21
Mechanism of intrinsic penicillin-resistance in Staphylococcus aureus. Binding of penicillin G to the cytoplasmic membrane of resistant staphylococci. Arzneimittelforschung (1980) 1.17
Modification of elongation-factor-Tu . guanine-nucleotide interaction by kirromycin. A comparison with the effect of aminoacyl-tRNA and elongation factor Ts. Eur J Biochem (1978) 1.16
Suppression of intrinsic resistance to penicillins in Staphylococcus aureus by polidocanol, a dodecyl polyethyleneoxid ether. Antimicrob Agents Chemother (1985) 1.13
DIABETEX--a decision support system for therapy of type I diabetic patients. Comput Methods Programs Biomed (1991) 0.96
Constitutive and cytokine-induced production of interleukin-6 by human myoblasts. Immunol Lett (1994) 0.95
Structure of the penicillin acylase gene from Escherichia coli: a periplasmic enzyme that undergoes multiple proteolytic processing. J Mol Appl Genet (1985) 0.94
Carbonic anhydrase in skeletal and cardiac muscle from rabbit and rat. Biochem J (1992) 0.88
Monoclonal antibodies specific to the glutamic acid decarboxylase 65 kDa isoform derived from a non-obese diabetic (NOD) mouse. Diabetes Res (1994) 0.88
Acoustic voice analysis by means of the hoarseness diagram. J Speech Lang Hear Res (2000) 0.87
Injuries in young athletes. Eur J Pediatr (2000) 0.87
Autoantibodies against GAD65 rather than GAD67 precede the onset of type 1 diabetes. Autoimmunity (1994) 0.87
Validity of WHO criteria for classification of newly diagnosed diabetics. Exp Clin Endocrinol (1985) 0.85
Carbonic anhydrase in the sarcoplasmic reticulum of rabbit skeletal muscle. J Physiol (1986) 0.84
[Objective description of voice quality using the hoarseness diagram]. HNO (1998) 0.83
Extracellular and membrane-bound beta lactamase of Staphylococcus aureus: their importance for the expression of penicillin resistance. J Med Microbiol (1987) 0.83
[Safety and efficacy of LK565--a new polymer ultrasound contrast medium]. Z Kardiol (2001) 0.83
Regulation of beta-lactamase synthesis as a novel site of action for suppression of methicillin resistance in Staphylococcus aureus. Zentralbl Bakteriol (1997) 0.82
Remission phase in newly diagnosed insulin treated juvenile diabetes: behaviour of glucose, FFA, HGH and total-IRI during combined glucose arginine infusion; development of antibodies against exogenous insulin. Endokrinologie (1973) 0.80
Incidence of type 1 diabetes in childhood before and after the reunification of Germany--an analysis of epidemiological data, 1960-2006. Exp Clin Endocrinol Diabetes (2012) 0.79
The identity of interferon-beta 1 mRNA transcripts in human fibroblasts and Namalva cells. FEBS Lett (1982) 0.79
Atherosclerosis as an autoimmune condition. Isr J Med Sci (1995) 0.79
Insulin antibodies in juvenile diabetes mellitus. Correlations to diabetic stability, insulin requirement and duration of insulin treatment. Horm Metab Res (1982) 0.79
Clinical and metabolic studies in children of diabetic-mothers. Endokrinologie (1976) 0.79
Effects of clofibrate therapy on glucose tolerance, insulin secretion and serum lipids in subjects with hyperlipoproteinemia and impaired glucose tolerance. A follow-up study over a five-year period. Exp Clin Endocrinol (1983) 0.78
Classification of diabetic neuropathy from pathogenetic aspects. Endokrinologie (1982) 0.78
Multilevel blazed gratings in resonance domain: an alternative to the classical fabrication approach. Opt Express (2011) 0.78
Erythrocyte sodium-lithium countertransport, adenosine triphosphatase activity and sodium-potassium fluxes in insulin-dependent diabetes. Int J Clin Lab Res (1995) 0.78
SIM--simultaneous inverse filtering and matching of a glottal flow model for acoustic speech signals. J Acoust Soc Am (2001) 0.78
Aberrant activation of CD8+ T-cell and CD8+ T-cell subsets in patients with newly diagnosed IDDM. Diabetes (1995) 0.78
Phagocytic activity of blood cells in diabetic risk probands and newly diagnosed type 1 diabetics. Exp Clin Endocrinol (1988) 0.77
Age-dependent relationship of fasting C-peptide concentration and insulin secretion in non-obese subjects with normal glucose tolerance. Exp Clin Endocrinol (1986) 0.77
Antibody response to islet antigens in anti-CD4/prednisolone immune intervention of type 1 diabetes. Int J Clin Lab Res (1996) 0.77
[Benign lactic acidosis in 2 female diabetics treated with insulin]. Vnitr Lek (1990) 0.77
Evidence for immunomodulatory properties of prolactin in selected in vitro and in vivo situations. Int J Immunopharmacol (1991) 0.77
The frequency of disturbances of somatic development in young people with type I diabetes in dependence on duration and age at onset of the disease. Exp Clin Endocrinol (1990) 0.77
[Incidence of gestational diabetes as well as changes in insulin secretion during pregnancy. 1. Studies on pregnant women suspected of diabetes using the glucose infusion test (GIT)]. Zentralbl Gynakol (1978) 0.77
[The diabetic polyneuropathy. I. Relation between impaired function in peripheral nerves and clinical findings]. Endokrinologie (1979) 0.76
Effect of growth hormone on the metabolic activity of phagocytes of peripheral blood in pituitary dwarfs and acromegaly. Endocrinol Exp (1982) 0.76
[Acoustic voice analysis. On documentation of voice rehabilitation after laser surgery laryngeal carcinoma resection]. HNO (1996) 0.76
Quantitative and qualitative changes in the early insulin response to glucose in subjects with impaired carbohydrate tolerance. Diabetes Care (1981) 0.76
Human pancreatic secretory trypsin inhibitor (PSTI) produced in active form and secreted from Escherichia coli. Gene (1988) 0.76
Differential expression of fructosyllysine-specific receptors on monocytes and macrophages and possible pathophysiological significance. Diabetologia (1996) 0.76
Mumps infection and insulin-dependent diabetes mellitus (IDDM). Diabetes Care (1984) 0.76
[Diabetes mellitus. XII. Oral diabetes therapy]. Z Arztl Fortbild (Jena) (1971) 0.75
[The effect of aminoglutethimide in the treatment of adrenal gland hyperfunction]. Z Gesamte Inn Med (1979) 0.75
[Diabetes mellitus. 8. Kidney complications in diabetes mellitus. The problem of microangiopathy]. Z Arztl Fortbild (Jena) (1970) 0.75
[Use of an artificial B-cell in clinic and experimental medicine]. Z Gesamte Inn Med (1981) 0.75
[On the treatment of diabetes mellitus with glycodiazin, an orally acting antidiabetic drug]. Dtsch Z Verdau Stoffwechselkr (1967) 0.75
[The new transplantation law. What must hospital physicians observe?]. Chirurg (1998) 0.75
[Treatment exceeding the limit of mandated health insurance]. Chirurg (1998) 0.75
[Treatment of hyperlipidemias with para-chlorphenoxyisobutyric acid (Regardin)]. Dtsch Gesundheitsw (1971) 0.75
Assessment of an algorithm for the artificial B-cell using the normal insulin-glucose relationship in diabetic dogs and men. Diabetologia (1980) 0.75
[Synthesis of benzylpenicillin-azo-ovalbumin]. Naunyn Schmiedebergs Arch Pharmakol (1969) 0.75
[Basic principles, procedure and tables for the computation of the average energy requirement]. Z Arztl Fortbild (Jena) (1977) 0.75
[Results of renal biopsies in 72 diabetics]. Z Gesamte Inn Med (1968) 0.75
[On the significance of Sternheimer-Malbin cells in the diagnosis of urinary tract infections and pyelonephritis in diabetics]. Z Gesamte Inn Med (1967) 0.75
[Diabetic polyneuropathy. 3. Electroneurographic findings in diabetics and their relationships to age and duration of diabetes]. Endokrinologie (1979) 0.75
[Temporary legal protection in fee conflicts. When can the social court help]. Chirurg (1997) 0.75
[Changes due to the 2nd reorganization law. What has changed for contract physicians since 1 July 1997?]. Chirurg (1997) 0.75
[Diabetes in pregnancy. A clinical and statistical analysis of 1800 pregnancies and deliveries from 1952-1971. I. Perinatal mortality in relation to the classification of White and delivery date]. Fortschr Geburtshilfe Gynakol (1975) 0.75
[Necrobiosis lipoidica diabetricorum and serum lipids]. Z Gesamte Inn Med (1976) 0.75
[A method of hemoglobin A-lc determination]. Z Gesamte Inn Med (1980) 0.75
[Analysis of Do9 action upon resistant staphylococci]. Naunyn Schmiedebergs Arch Pharmakol (1970) 0.75
[Counseling aids for chief physician service contracts]. Chirurg (2003) 0.75
[Diabetes in pregnancy. A clinical and statistical analysis of 1800 pregnancies and deliveries from 1952-71. II. Perinatal mortality in relation to the treatment of diabetes and the frequency of toxemia and urinary tract infections]. Fortschr Geburtshilfe Gynakol (1975) 0.75
[Secondary hyperlipoproteinemias]. Z Gesamte Inn Med (1977) 0.75
[Diet therapy of diabetes mellitus]. Z Arztl Fortbild (Jena) (1978) 0.75
[Missed thrombosis diagnosis--flagrant malpractice? Decision of the Oldenburg supreme court 25 November 1997--5 U 66/97]. Chirurg (1998) 0.75
[Current status of antacids in hypersecretory and ulcerative diseases of the stomach and duodenum]. ZFA (Stuttgart) (1978) 0.75
[GOA--Settlement on hip joint surgery. Principle of payment limit. Decision of the Karlsruhe District Court of 3/28/2003-1 S 106.02]. Chirurg (2003) 0.75
[Stability to penicillinase of a penicillin-protein conjugate]. Naunyn Schmiedebergs Arch Pharmakol (1970) 0.75
[Comparative studies with various carbohydrate metabolism loading in gastrectomized patients]. Z Gesamte Inn Med (1966) 0.75
[Circadian variations in insulin concentrations and blood glucose in non-diabetics as well as insulin requirements in insulin-dependent diabetics]. Z Gesamte Inn Med (1981) 0.75
[On call service is work time. Decision of the European Court 3 October 2000]. Chirurg (2001) 0.75
[Protection from competition in public health law. Decision of the Federal Social Court 28 August 1996 (6 RKa 37/95)]. Chirurg (1997) 0.75
[Assessment of kidney function in diabetics by measurement of osmotic concentration ability]. Dtsch Z Verdau Stoffwechselkr (1969) 0.75
[Diabetic polyneuropathy. 4. Synopsis of electroneurographic findings in diabetics]. Endokrinologie (1979) 0.75
[Influencing of intracellular phage development in staphylococci]. Naunyn Schmiedebergs Arch Pharmakol (1970) 0.75
[The diabetic polyneuropathy. II. Polyneuropathy, angiopathy and nerve conduction velocity]. Endokrinologie (1979) 0.75
[Influencing of resistance of Staphylococci against penicillin by alkylpolyglycelether]. Arzneimittelforschung (1967) 0.75
[The physician's responsibility for confidentiality in the hospital]. Chirurg (1998) 0.75
[Necessary reference to the life threatening state of an infection. On the surgeon's management of hesitant patients]. Chirurg (2000) 0.75
Binding characteristics of various penicillins in Staphylococcus aureus. Arzneimittelforschung (1981) 0.75
[Inactivation of penicillin in antisera of a synthetic penicillin antigen]. Naunyn Schmiedebergs Arch Pharmakol (1969) 0.75
[An immunological inactivation of penicillin]. Naunyn Schmiedebergs Arch Pharmakol (1969) 0.75
[Applying for medical chief position--negotiating with success]. Chirurg (1998) 0.75
[On experiences with deponal-insulin, a new depot insulin from VEB Berlin Chemie]. Dtsch Gesundheitsw (1966) 0.75
[Comparison of the phenol red test with results of the PAH clearance in patients with diabetes mellitus and variable diabetic complications]. Z Gesamte Inn Med (1966) 0.75
DIABETEX decision module 2--calculation of insulin dose proposals and situation recognition by means of classifiers. Comput Methods Programs Biomed (1991) 0.75
[Clinical studies on pyelonephritis and its differential diagnosis in diabetes mellitus with special reference to modern nephrologic examination technics]. Munch Med Wochenschr (1971) 0.75
[Clofibrate in the treatment of diabetic retinopathy]. Vestn Oftalmol (1979) 0.75
[The use of artificial beta-cells or programmed insulin infusions in the therapy of insulin-dependent diabetes mellitus]. Z Gesamte Inn Med (1981) 0.75
[On the problem of tolbutamide dosage in the oral treatment of diabetes mellitus, simultaneously on the problem of late failure]. Dtsch Z Verdau Stoffwechselkr (1967) 0.75